<DOC>
	<DOCNO>NCT00502242</DOCNO>
	<brief_summary>The primary objective study determine efficacy ramipril prevent urinary protein creatinine ratio ( U p/c ) great 0.5 follow conversion sirolimus calcineurin inhibitor ( CNI ) maintenance kidney transplant patient .</brief_summary>
	<brief_title>Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus</brief_title>
	<detailed_description />
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Receiving cyclosporine ( CsA ) tacrolimus ( TAC ) since first month posttransplant . In addition calcineurin inhibitor ( CNI ) , subject must treat either corticosteroid dosage range 2.5 15 mg/day prednisone prednisolone ( 2 12mg/day methylprednisolone alternate day equivalent ) steroidfree regimen minimum 12 week randomization either MMF ( &gt; /=500mg/day ) , mycophenolate sodium ( MPS ) ( &gt; /=360 mg/day ) AZA ( &gt; /=50mg/day ) . Subjects must take minimum 2 immunosuppressive drug steroidfree regimen . Subject 3 60 month renal transplantation . Subject great 12 week treatment acute rejection . Subjects currently receive , receive within 4 week enrollment , RAAS blockade . Subjects calculate GFR &lt; 40mL/min ( per Modification Diet Renal Disease [ MDRD7 ] abbreviate MDRD formula ) . Subjects urine protein creatinine ratio ( U p/c ) &gt; 0.3 . Subjects history uncontrolled systolic blood pressure ( SBP &gt; 140 mm Hg ) . Subjects severe hepatic impairment ( Grade C ChildPugh score ) . Additional Inclusion / Exclusion Criteria apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>